Dr. David Kessler, M.D

NPI: 1538255765
Total Payments
$424,231
2024 Payments
$52.84
Companies
3
Transactions
17

Payment Breakdown by Category

Other$250,000 (58.9%)
Consulting$160,000 (37.7%)
Travel$14,107 (3.3%)
Food & Beverage$124.45 (0.0%)

Payments by Nature

Nature of Payment Amount Transactions Share
Acquisitions $250,000 1 58.9%
Consulting Fee $160,000 5 37.7%
Travel and Lodging $14,107 7 3.3%
Food and Beverage $124.45 4 0.0%

Top Paying Companies

Company Total Records Latest Year
Immucor, Inc. $424,107 13 $0 (2023)
Janssen Pharmaceuticals, Inc $102.12 3 $0 (2024)
Janssen Biotech, Inc. $22.33 1 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $52.84 2 Janssen Pharmaceuticals, Inc ($30.51)
2023 $250,072 3 Immucor, Inc. ($250,000)
2020 $40,000 2 Immucor, Inc. ($40,000)
2019 $45,206 4 Immucor, Inc. ($45,206)
2018 $42,745 3 Immucor, Inc. ($42,745)
2017 $46,156 3 Immucor, Inc. ($46,156)

All Payment Transactions

17 individual payment records from CMS Open Payments

Date Company Product Nature Form Amount Type
10/24/2024 Janssen Biotech, Inc. TREMFYA (Drug) Food and Beverage In-kind items and services $22.33 General
Category: Immunology
06/16/2024 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $30.51 General
Category: Cardiovascular & Metabolism
03/21/2023 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $38.42 General
Category: Cardiovascular & Metabolism
03/16/2023 Immucor, Inc. Acquisitions Cash or cash equivalent $250,000.00 General
01/23/2023 Janssen Pharmaceuticals, Inc XARELTO (Drug) Food and Beverage In-kind items and services $33.19 General
Category: Cardiovascular & Metabolism
12/03/2020 Immucor, Inc. Consulting Fee Cash or cash equivalent $30,000.00 General
03/03/2020 Immucor, Inc. Consulting Fee Cash or cash equivalent $10,000.00 General
12/04/2019 Immucor, Inc. Consulting Fee Cash or cash equivalent $40,000.00 General
10/15/2019 Immucor, Inc. Travel and Lodging Cash or cash equivalent $1,275.75 General
05/28/2019 Immucor, Inc. Travel and Lodging Cash or cash equivalent $1,098.82 General
05/16/2019 Immucor, Inc. Travel and Lodging In-kind items and services $2,831.46 General
12/03/2018 Immucor, Inc. Consulting Fee Cash or cash equivalent $40,000.00 General
06/20/2018 Immucor, Inc. Travel and Lodging Cash or cash equivalent $213.02 General
05/25/2018 Immucor, Inc. Travel and Lodging Cash or cash equivalent $2,532.12 General
12/06/2017 Immucor, Inc. Consulting Fee Cash or cash equivalent $40,000.00 General
06/06/2017 Immucor, Inc. Travel and Lodging Cash or cash equivalent $2,818.30 General
01/13/2017 Immucor, Inc. Travel and Lodging Cash or cash equivalent $3,337.20 General

About Dr. David Kessler, M.D

Dr. David Kessler, M.D is a Pediatrics healthcare provider based in San Francisco, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/05/2006. The National Provider Identifier (NPI) number assigned to this provider is 1538255765.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. David Kessler, M.D has received a total of $424,231 in payments from pharmaceutical and medical device companies, with $52.84 received in 2024. These payments were reported across 17 transactions from 3 companies. The most common payment nature is "Acquisitions" ($250,000).

Practice Information

  • Specialty Pediatrics
  • Location San Francisco, CA
  • Active Since 10/05/2006
  • Last Updated 08/05/2022
  • Taxonomy Code 208000000X
  • Entity Type Individual
  • NPI Number 1538255765

Products in Payments

  • XARELTO (Drug) $102.12
  • TREMFYA (Drug) $22.33

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Pediatrics Doctors in San Francisco